NSIS B — Novozymes A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK194.29bn
- DKK201.24bn
- DKK17.90bn
Annual cashflow statement for Novozymes A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,155 | 2,826 | 3,145 | 3,686 | 3,039 |
| Depreciation | |||||
| Non-Cash Items | 139 | 954 | 782 | 450 | 766 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,280 | -691 | -1,281 | -1,615 | -1,042 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,196 | 4,355 | 4,062 | 4,006 | 4,152 |
| Capital Expenditures | -997 | -940 | -1,240 | -2,890 | -2,056 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 436 | -584 | -1,507 | 218 | -77 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -561 | -1,524 | -2,747 | -2,672 | -2,133 |
| Financing Cash Flow Items | -1 | -294 | -1 | -1 | -31 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,644 | -2,314 | -1,586 | -1,250 | -1,889 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12 | 470 | -218 | 78 | 75 |